Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/15 → 6/1/17 |
Funding
- Chimerix, Inc.
CMX001-304: A Phase 3, Open-label, Multicenter Study of the Safety/Tolerability and Efficacy of Brincidofovir(CMX001) for the Prevention of Adenovirus (AdV) Disease in Subjects with Asymptomatic AdV Infection at Risk of Progres
- Chaudhury, Sonali (PD/PI)
- Muller, William J (Co-Investigator)
Project: Research project